Answers are grounded in this paper and cite their sources.
This review examines the medicinal properties of Euphorbia tirucalli, suggesting new avenues for its therapeutic use.
In this review, we looked at medicinal plants that are used to treat various illnesses. These are a few of the naturally occurring herbal plants that have a wide range of chemical components that are used to cure different diseases. Because of their high activity and lack of side effects, herbal plants play a significant role in treatment. The taxonomy distribution, colloquial names, phytoconstituents, morphology, pharmacological activity, medicinal applications, conclusion, and references of the plants were all examined in this review. Euphorbiaceus is commonly known as Barki-thohar. This plant is native to America but has become acclimatised and grows freely in all parts of India. This is a common medicinal plant of India the plant parts used milky juice and stem bark. Milky juice in small doses is a purgative but in large doses it is acrid, counter-irritant and emetic. E. tirucallilatex seems to reduce the specific cellular immunity associated with the virus Epstein-Barr injection by activating the virus lytic cycle. The bark / latex of E. tirucalli presents pharmacological activities as anantibacterial, molluscicide, antiherpetic and anti-mutagenic. It also shows co-carcinogenic and anticarcinogenic activities. In the northeast region in Brazil, the latex of E. tirucalliis is used as a folk medicine against syphilis. As an antimicrobial; a laxative agent to control intestinal parasites to treat asthma, cough, earache, rheumatism, verrucae, cancer, epithelioma, sarcoma and skin tumors. E. tirucallicontains a large quantity of terpenes and sterols among its constituent and the following substances which have been isolated; alcohol eufol, alfaeuforbol and taraxa sterol e tirucallol. This review highlights the existing information particularly on the phytochemistry and various pharmacological properties of Euphorbia tirucalli which may provide incentive for proper evaluation of the plant as a medicinal agent.
No takes yet. Share an insight, caveat, or question.
Dr. Karpagam P.2 Ms. M. Subhikshaa1* (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: